Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy
- Status
- COMPLETED
- Phase
- N/A
Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in France
- Status
- TERMINATED
- Phase
- N/A
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Status
- RECRUITING
- Phase
- PHASE3
Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
- Status
- RECRUITING
- Phase
- N/A
Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection
- Status
- RECRUITING
- Phase
- N/A
COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Real-World Use of Nivolumab for the Treatment of Patients With Metastatic Upper Gastrointestinal Cancer in Canada
- Status
- COMPLETED
- Phase
- N/A
Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada
- Status
- COMPLETED
- Phase
- N/A
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Status
- RECRUITING
- Phase
- N/A
A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) Patients
- Status
- COMPLETED
- Phase
- N/A
Real-World Effectiveness of Mavacamten in Canada
- Status
- COMPLETED
- Phase
- N/A
Testing the Engaged Approach to Lung Cancer Screening
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan
- Status
- COMPLETED
- Phase
- N/A
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE2